Cargando…

Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation

BACKGROUND: This study aimed to determine clinical outcomes using various drugs during tuberculosis (TB) treatment among living donor liver transplant (LDLT) recipients with TB and to assess the impact of performing LDLT in patients with active TB at the time of LDLT. MATERIAL/METHODS: Out of 1313 L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvador, Noruel Gerard A., Wee, Sin-Yong, Lin, Chih-Che, Wu, Chao-Chien, Lu, Hung-I, Lin, Ting-Lung, Lee, Wei-Feng, Chan, Yi-Chia, Lin, Li-Man, Chen, Chao-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248277/ https://www.ncbi.nlm.nih.gov/pubmed/30337516 http://dx.doi.org/10.12659/AOT.911034

Ejemplares similares

Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis
por: Wang, Yu-Chen, et al.
Publicado: (2021)

Complications of percutaneous liver biopsy in living donor liver transplantation: Two case reports
por: Chiu, King-Wah, et al.
Publicado: (2018)

Long-term renal outcomes comparison between patients with chronic kidney disease and hepatorenal syndrome after living donor liver transplantation
por: Tseng, Hsiang-Yu, et al.
Publicado: (2023)

Clinical Beneficial Effects of Using Crystalloid only in Recipients of Living Donor Liver Transplantation
por: Huang, Chia-Jung, et al.
Publicado: (2017)

Sarcopenia adversely impacts postoperative complications in living-donor liver transplantation recipients
por: Wu, Mei-Yun, et al.
Publicado: (2021)

Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2016)

Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation
por: Wu, Ming-Kung, et al.
Publicado: (2018)

Can Microscopic Biliary Reconstruction Reduce Biliary Complication Rate in ABO-Incompatible Adult Living Donor Liver Transplantation?
por: Lin, Yu-Cheng, et al.
Publicado: (2021)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Using 3D Microscope for Hepatic Artery Reconstruction in Living Donor Liver Transplant
por: Lin, Ching-Min, et al.
Publicado: (2022)

Impacts of Pretransplant Infections on Clinical Outcomes of Patients with Acute-On-Chronic Liver Failure Who Received Living-Donor Liver Transplantation
por: Lin, Kuo-Hua, et al.
Publicado: (2013)

Excess Risk of Major Adverse Cardiovascular and Kidney Events after Acute Kidney Injury following Living Donor Liver Transplantation
por: Chan, Yi-Chia, et al.
Publicado: (2022)

Living Donor Intestinal Transplantation: Recipient Outcomes
por: Wu, Guosheng, et al.
Publicado: (2022)

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation
por: Chen, I-Hsuan, et al.
Publicado: (2023)

Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys
por: Dharia, Atit A., et al.
Publicado: (2022)

Impact of Thyroid Incidentaloma on Liver Transplant: A Study of 1010 Recipients at a Single Center
por: Chan, Yi-Chia, et al.
Publicado: (2022)

Proteinuria and baseline renal function predict mortality and renal outcomes after sirolimus therapy in liver transplantation recipients
por: Li, Lung-Chih, et al.
Publicado: (2017)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation
por: Zhang, Fan, et al.
Publicado: (2021)

Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023)

Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
por: Dar, Faisal S, et al.
Publicado: (2019)

Effect of donor kidney morphology parameters on the prognosis in living kidney transplantation recipients
por: Qiu, Yang, et al.
Publicado: (2020)

Effect of donor-specific antibodies and panel reactive antibodies in living donor liver transplant recipients
por: Song, Seung Hwan, et al.
Publicado: (2015)

Pyrosequencing to Identify Homogeneous Phenomenon When Using Recipients/Donors with Different CYP3A5*3 Genotypes in Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2013)

Head and neck cancer in living donor liver transplant recipients: Single center retrospective study
por: Lin, Nan-Chin, et al.
Publicado: (2019)

Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients
por: Imai, Shunichi, et al.
Publicado: (2018)

Characteristics and Prognosis of Stroke in Living Donor Renal Transplant Recipients
por: Mizuno, Takafumi, et al.
Publicado: (2022)

The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline
por: Miller, Charles M., et al.
Publicado: (2017)

Association of Hematuria with Renal Progression and Survival in Patients Who Underwent Living Donor Liver Transplant
por: Chang, Kai-Chieh, et al.
Publicado: (2021)

Association between Subclinical Low Serum 25(OH)D in Donors and Fatty Liver Disease in Recipients after Living Donor Liver Transplantation
por: Chiu, King-Wah, et al.
Publicado: (2018)

Identification of IL-28B Genotype Modification in Hepatocytes after Living Donor Liver Transplantation by Laser Capture Microdissection and Pyrosequencing Analysis
por: Chiu, King-Wah, et al.
Publicado: (2018)

Simpson's paradox and the impact of donor-recipient race-matching on outcomes post living or deceased donor kidney transplantation in the United States
por: Lv, Kaikai, et al.
Publicado: (2023)

HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2021)

Cytochrome P450 in living donor liver transplantation
por: Chiu, King-Wah, et al.
Publicado: (2015)

Poor outcomes of early recurrent post-transplant bloodstream infection in living-donor liver transplant recipients
por: Kim, Si-Ho, et al.
Publicado: (2020)

Quantifying infection risks in incompatible living donor kidney transplant recipients
por: Avery, Robin K., et al.
Publicado: (2020)

Varicella Infection in an Immunized Pediatric Living Donor Liver-Transplant Recipient
por: Mehta, Vibha, et al.
Publicado: (2021)

Increasing the Rate of Living Donor Kidney Transplantation in Ontario: Donor- and Recipient-Identified Barriers and Solutions
por: Getchell, Leah E., et al.
Publicado: (2017)

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases
por: Hernandez-Alejandro, Roberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_honqth70vc864n13j8o0r5gngc